Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

286 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study.
Ditzenberger GL, Lake JE, Kitch DW, Kantor A, Muthupillai R, Moser C, Belaunzaran-Zamudio PF, Brown TT, Corey K, Landay AL, Avihingsanon A, Sattler FR, Erlandson KM. Ditzenberger GL, et al. Among authors: avihingsanon a. Clin Infect Dis. 2024 Jul 24:ciae384. doi: 10.1093/cid/ciae384. Online ahead of print. Clin Infect Dis. 2024. PMID: 39046173
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.
Simonsen L, Higgs E, Taylor RJ, Wentworth D, Cozzi-Lepri A, Pett S, Dwyer DE, Davey R, Lynfield R, Losso M, Morales K, Glesby MJ, Weckx J, Carey D, Lane C, Lundgren J; INSIGHT FLU002 and FLU003 Study Groups. Simonsen L, et al. Clin Infect Dis. 2018 Jul 18;67(3):341-349. doi: 10.1093/cid/ciy088. Clin Infect Dis. 2018. PMID: 29746631 Free PMC article.
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.
Cahn P, Kaplan R, Sax PE, Squires K, Molina JM, Avihingsanon A, Ratanasuwan W, Rojas E, Rassool M, Bloch M, Vandekerckhove L, Ruane P, Yazdanpanah Y, Katlama C, Xu X, Rodgers A, East L, Wenning L, Rawlins S, Homony B, Sklar P, Nguyen BY, Leavitt R, Teppler H; ONCEMRK Study Group. Cahn P, et al. Among authors: avihingsanon a. Lancet HIV. 2017 Nov;4(11):e486-e494. doi: 10.1016/S2352-3018(17)30128-5. Epub 2017 Sep 11. Lancet HIV. 2017. PMID: 28918877 Clinical Trial.
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Chang VK, Imperial MZ, Phillips PPJ, Velásquez GE, Nahid P, Vernon A, Kurbatova EV, Swindells S, Chaisson RE, Dorman SE, Johnson JL, Weiner M, Sizemore EE, Whitworth W, Carr W, Bryant KE, Burton D, Dooley KE, Engle M, Nsubuga P, Diacon AH, Nhung NV, Dawson R, Savic RM; AIDS Clinical Trial Group; Tuberculosis Trials Consortium. Chang VK, et al. Nat Commun. 2024 Oct 30;15(1):9400. doi: 10.1038/s41467-024-53273-7. Nat Commun. 2024. PMID: 39477924 Clinical Trial.
Circulating capsid-antibody-complexes (CACs) drive intrahepatic complement deposition and inform subclinical liver inflammation in chronic hepatitis B.
Tang Y, Xu M, Wang C, Wu M, Hu L, Li J, Lu W, Zheng Y, Zhang M, Jiang X, Zhu C, Audsley J, Tangkijvanich P, Avihingsanon A, Song S, Liu S, Lewin SR, George J, Douglas MW, Ling Y, Yuan Z, Zhu L, Zhang Z, Zhang X. Tang Y, et al. Among authors: avihingsanon a. Antiviral Res. 2024 Oct 11;231:106017. doi: 10.1016/j.antiviral.2024.106017. Online ahead of print. Antiviral Res. 2024. PMID: 39396554
The population pharmacokinetics of dolutegravir co-administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens.
Punyawudho B, Chanruang A, Ueaphongsukkit T, Gatechompol S, Ubolyam S, Cho YS, Shin JG, Avihingsanon A. Punyawudho B, et al. Among authors: avihingsanon a. CPT Pharmacometrics Syst Pharmacol. 2024 Sep 23. doi: 10.1002/psp4.13244. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 39311391 Free article.
Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics.
Zaniewski E, Skrivankova VW, Brazier E, Avihingsanon A, Cardoso SW, Cesar C, Chenal H, Crabtree-Ramírez BE, Ditangco RA, Ebasone PV, Eley B, Euvrard JG, Fatti G, Huwa JM, Lelo P, Machado DM, Messou EK, Minga AK, Muleebwa J, Mundhe S, Murenzi G, Muyindike WR, Nsonde DM, Obatsa SM, Odhiambo J, Prozesky HW, Rungmaitree S, Semeere AS, Seydi M, Sipambo N, Sudjaritruk T, Technau KG, Tiendrebeogo T, Twizere C, Ballif M. Zaniewski E, et al. Among authors: avihingsanon a. AIDS. 2024 Sep 5. doi: 10.1097/QAD.0000000000004007. Online ahead of print. AIDS. 2024. PMID: 39236112
286 results